Recent Patents on CNS Drug Discovery

ISSN: 1574-8898 - Volume 3, 3 Issues, 2008

Editor-in-Chief:

Khurshid Zaman
Bentham Science Publishers Ltd.

Editorial Advisory Board:

A. Adell (Instituto de Investigaciones Biomedicas de Barcelona, Barcelona, Spain)
J.A.G. Agúndez (Univ. of Extremadura, Badajoz, Spain)
N. Ait-Aissa (Actelion Pharmaceuticals, Paris, France)
J. Alberch (University of Barcelona, Barcelona, Spain)
P. Alewood (Univ. of Queesland, Brisbane, Australia)
L.F. Alguacil (Univ. San Pablo CEU, Madrid, Spain)
D.L. Alkon (Blanchette Rockefeller Neurosci. Inst., Rockville, MD, USA)
A.F. Ambrosio (University of Coimbra, Coimbra, Portugal)
S. Ananthan (Southern Research Institute, Birmingham, AL, USA)
A. Andjelkovic-Zochowska (Univ. of Michigan, Ann Arbor, MI, USA)
O.I. Aruoma (London South Bank University, London, UK)
C. Atwood (Univ. of Wisconsin-Madison Med. Sch., Madison, WI, USA)
K. Aubrey (CNRS, Paris, France)
J. Avila (Universidad Autonoma de Madrid, Madrid, Spain)
S. Bachurin (Institute of Physiologically Active Compounds, Russia)
W. Balduini (Universita di Urbino, Chiara, Italy)
D.C. Baumgart (Humboldt-University of Berlin, Berlin, Germany)
N.G. Bazan (LSU Neuroscience Center of Excellence, New Orleans, LA, USA)
G. Benitez-King (Instituto Nacional de Psiquiatria, Mexico)
I. Berdicevsky (Technion - Israel Institute of Techno, Haifa, Israel)
K. Beyer (University Germans Trials I Pujol, Barcelona, Spain)
S. Bhattacharyya (Inst.of Psychiatry, London, UK)
G. Binetti (Memory Clinic, Neuro. Bio. Gen. Lab., Brescia, Italy)
B. Bodey (University of Southern California, California, CA, USA)
J. Bogousslavsky (Univ. Dept. of Neurology, CHUV, Lausanne, Switzerland)
R.M. Bonelli (Graz Medical University, Graz, Austria)
G. Bonfiglio (Clinical and Functional Research Laboratory, Catania, Italy)
S.L. Borgland (University of California, San Francisco, California, USA)
L. Brand (North West University, Potchefstroom, South Africa)
M.A. Brimble (University of Auckland, Auckland, New Zealand)
C.B. Brink (North West University, Potchefstroom, South Africa)
P. Buckley (Medical College of Georgia, Augusta, Georgia, GA, USA)
S.J. Busch (Sanofi-Aventis Pharmaceuticals, Bridgewater, NJ, USA)
R. Cacabelos (Camilo Jose Cela University, Madrid, Spain)
B. Cacciari (Università di Ferrara, Ferrara, Italy)
S.X. Cai (EpiCept Corporation, San Diego, CA, USA)
M. Castanho (University of Lisbon, Lisbon, Portugal)
E. Castrén (Univ. of Helsinki, Helsinki, Finland)
A. Contestabile (University of Bologna, Bolonga, Italy)
M. Coster (University of Sydney, Sydney, Australia)
S. Chaki (Medicinal Research Laboratories,Taisho Pharmaceuticals, Saitama, Japan)
M. Chorev (Harvard Medical School, Cambridge, MA, USA)
J.R. Connor (Penn State College of Medicine, Hershey, PA, USA)
A.C. Cuello (McGill University, Quebec, Canada)
J.L. Cummings (David Geffen Sch. of Med. at UCLA, Los Angeles, CA, USA)
M. Curras-Collazo (Univ. of California, Riverside, CA ,USA)
T. del Ser (Neuropharma S.A., Madrid, Spain)
V. Di Marzo (CNR, Naples, Italy)
T. Dohi (Hiroshima Univ. Grad. Sch. Biomed. Sci., Hiroshima, Japan)
P. Donnelly (University of Melbourne, Melbourne, Australia)
B.M. Dunn (Univ. of Florida, Gainesville, FL, USA)
V.G. Duschak (Instituto Nacional de Parasitología, Buenos Aires, Argentina)
S.I. Dworkin (University of North Carolina Wilmington, Wilmington, NC, USA)
G. Egea (Univ. Barcelona, Barcelona, Spain)

M. Engström (Juvantia Pharma Ltd., Turku, Finland)
F. Entschladen (Witten/Herdecke University, Witten, Germany)
R. Faghih (Abbott Laboratories, Houston, TX, USA)
M. Faria (Instituto Butantan Av Vital, Sao Paulo, Brazil)
S. Ferre (National Institute on Drug Abuse, Baltimore, MD, USA)
H. Fillit (Institute for Study of Aging, New York, NY, USA)
G. Foster (University of Wales, Wales, UK)
P. Franchetti (University of Camerino, Camerino, Italy)
P. Francotte (Universite de Liege, Liege, Belgium)
J. Friedman (D-Pharm Ltd., Rehovot, Israel)
S.E. Gandy (Thomas Jefferson University, Philadelphia, PA, USA)
A.G. Garcia (UAM, Madrid, Spain)
V. Gentile (Second Univ. Naples, Naples, Italy)
A. Galal (Univ. of Mississippi, Mississippi, MS, USA)
M. Glatzel (Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany)
R.A. Glennon (Virginia Commonwealth University, Richmond, VA, USA)
A.V. Glushakov (University of Florida, Gainesville, FL , USA)
B. Gold (Oregon Health & Science University, Oregon, OR, USA)
I. Gozes (Tel Aviv University, Tel Aviv, Israel)
D.K. Grandy (Oregon Health and Science University, Portland, OR, USA)
N.H. Greig (Drug Design & Develop. Sec., NIH, Baltimore, MD, USA)
B. Grimpe (University of Miami, Miami, FL, USA)
J. Guan (University of Auckland, Auckland, New Zealand)
A. Guiotto (CNR, Naples, Italy)
H.-J. Ha (Hankuk University of Foreign Studies, Yongin, Kyunggi-Do, Korea)
J.J. Hagan (GlaxoSmithkline Plc, Essex, UK)
J.C.G. Halford (University of Liverpool, Liverpool, UK)
A.J. Hannan (University of Melbourne, VIC, Australia)
T. Hartmann (University of Heidelberg, Heidelberg, Germany)
J.A. Harrold (University of Liverpool, Liverpool, UK)
B. H. Harvey (North West University, Potchefstroom, South Africa)
K. Hashimoto (Chiba University Graduate School of Medicine, Chiba, Japan)
F.F. Hefti (Radiopharmaceuticals, Philadelphia, PA 19104, USA)
C. Heidbreder (GlaxoSmithKline Pharmaceut., Verona, Italy)
C. Henchcliffe (Cornell Univ., Ithaca, NY, USA)
G. Henriksen (Technische Universität München,München, Germany)

L. Hertz (University of Saskatchewan, Saskatoon, Canada)
G. A. Kenna (Brown Univ., Providence, RI, USA)
E. Klann (Baylor College of Medicine, Houston, TX , USA)
R.C. Hogg (University of Geneva - CMU, Geneva, Switzerland)
F. Holsboer (Max Planck Institute Psychiatry, Munich, Germany)
S. Hood (University of Western Australia, Perth, Australia)
P. Houghton (King's College London, London, UK)
P. Huertas (Amicus Therapeutics, Inc., Cranbury, NJ, USA)
N.C. Inestrosa (Catholic University of Chile, Santiago, Chile)
A. Inui (Kagoshima University, Kagoshima, Japan)
E. Jacotot (THERAPTOSIS, Biocitech Technology Park, Cedex, France)
D. Janigro (Cleveland Clinic Lerner Coll. of Med., Cleveland, OH, USA)
E. Jirillo (University of Bari, Bari, Italy)
C.N. Johnson (GlaxoSmithKline, Harlow, UK)
A. Jones (Guy's/St. Thomas' Hosp. NHS Trust, London, UK)
J. Jordán (University of Castilla-La Mancha, Albacete, Spain)
J.R. Kanwar (Deakin University, Victoria, Australia)
M. Kassiou (University of Sydney, Sydney, Australia)
G. Katsuura (Shionogi & Co. Ltd., Osaka, Japan)
V. Kecskemeti (Semmelweis University, Budapest, Hungary)
S. Khanna (Psychiatric Clinic, New Delhi, India)
T. Kikuchi (Otsuka Pharmaceutical Co., Ltd.,Tokushima, Japan)
K. Konno (Butantan Institute, Sao Paulo, Brazil)
G.J. Kotwal (University of Cape Town, Cape Town, South Africa)
R.H. Lachmann (University of Cambridge, Cambridge, UK)
F. Lallemend (Karolinska Inst., MBB, Stockholm, Sweden)

J. Lange (Solvay Pharmaceuticals, Weesp, The Netherlands)
L. Lecanu (Georgetown University, Washington DC, USA)
F. Lesage (Université de Nice Sophia Antipolis, Paris , France)
W. Lim (Universiti Malaysia Sarawak,Sarawak,Malaysia)
L. Lindemann (F. Hoffmann-La Roche Ltd., Basel, Switzerland)
S.A. Lipton (Ctr. Neurosci and Aging,The Burnham Inst., San Diego, CA, USA)
T. Lundstedt (Uppsala University, Uppsala, Sweden)
A. Machado (Universidad de Sevilla, Seville, Spain)
K. Maiese (Wayne State University School of Medicine, Detroit, MI, USA)
J.O. Malva (University of Coimbra, Coimbra, Portugal)
K.G. Manton (Ctr. for Demographic Studies Duke Univ., North Carolina, NC, USA)
J.L.Marco-Contelles (Instituto de Quimica Organica General, Madrid, Spain)
P.M. Martin (University of Virginia Hlth. Sys.,Charlottesville, VA , USA)
A. Martinez (Instituto de Quimica Medica-CSIC, Madrid, Spain)
A.E. Martynyuk (University of Florida, Gainesville, FL, USA)
Y. Masuda (Tashirodai Hospital, Yamaguchi, Japan)
H. Mattes (Novartis Inst. Biomed. Res., Basel, Switzerland)
K.I. Maynard (Sanofi-Aventis, New Jersey, NJ, USA)
J. McGivern (Amgen Inc.Thousand Oaks, California, CA, USA)
M. McKenna (University of Maryland School of Medicine, Baltimore, MD, USA)
M. Medina (Neuropharma S.A., Madrid, Spain)
R.M. Melotti (University of Bologna, Bologna, Italy)
A. Messeguer (IIQAB-CSIC, Barcelona, Spain)
J.S. Meyer (Baylor College of Medicine, Houston, Texas, TX, USA)
D. Mitsikostas (Athens Naval Hospital, Athens, Greece)
H. Mochizuki (Department of Neurlogy, Tokyo, Japan)
S. De La Monte (Rhode Island Hosp. & Brown Med. Sch., Rhode Island , RI, USA)
A. Mora (Univ.Massachusetts Med Sch.,Worcester, MA, USA)
J. Nagy (Gedeon Richter Ltd., Budapest, Hungary)
N.-H. Nam (Hanoi University of Pharmacy, Hanoi, Vietnam)
V. Neugebauer (University of Texas Medical Branch, Galveston, TX, USA)
S.S. Nikam (Pfizer Global Research and Development, Ann Arbor, MI, USA)
J. Nilsen (University of Southern California, Los Angeles, CA, USA)
L. Ning (Sichuan University, Chengdu, China)
F. Nyberg (Uppsala University, Uppsala, Sweden)
M.J. O'Neill (Elli Lilly & Co. Ltd., Surrey, UK)
B. Onteniente (Universite Paris-Val-de-Marne, Paris, France)
D.W. Oliver (University of Reading, Reading, UK)
K. Parang (University of Rhode Island, Kingston, RI, USA)
G.M. Pastores (New York University School of Medicine, New York, NY, USA)
L. Peng (China Med. Univ., Shenyang, China)
M.L. Penichet (University of California, Los Angeles, CA, USA)
B. Platt (University of Aberdeen, Foresterhill, Aberdeen, Scotland, UK)
K. Pong (Wyeth Research, Princeton, NJ, USA)
R. Porter (F. Hoffmann-La Roche Ltd., Basel, Switzerland)
H. Potschka (Univ. of Vet. Med. Hannover, Hannover, Germany)
T. Prisinzano (University of Iowa, Iowa, IA, USA)
R.R. Puertas (University of Pa’s Vasco, Vizcaya, Spain)
A.I. Qureshi (Univ.Med.& Dentistry of New Jersey, New Jersey, NJ, USA)
M. P. Rathbone (McMaster University Health Sciences Centre, ON, Canada)
R. Reinscheid (University of California, Irvine, CA ,USA)
A.B. Reitz (Johnson & Johnson Pharmaceutical, Spring House, PA, USA)
P. Rameshwar (Department of Medicine-Hematology, Newark, NJ, USA)
L. Roberts (Royal North Shore Hospital, Sydney, Australia)
G.C. Roman (Univ. of Texas Health Sci. Ctr., San Antonio, TX, USA)
I. Rubinstein (University of Illinois at Chicago, Chicago, Illinois, IL, USA)
K.H. Ruan (Univ. of Texas-Houston Health Sci. Center, Houston, TX, USA)
B. Safieh-Garabedian (American University of Beirut, Beirut, Lebanon)
G. Sanacora (Yale University School of Medicine, Connecticut, CT, USA)
H.B. Schiöth (Uppsala University, Uppsala, Sweden)
B. Schmidt (Inst. Org. Chem. & Biochem., Darmstadt, Germany)
J.S. Schneider (Thomas Jefferson University, Philadelphia, PA, USA)
A. Schousboe (The Danish Univ.Pharmaceut.Sci., Copenhagen, Denmark)
T. Schwartz (SUNY Upstate Medical University, Syracuse, NY, USA)
A. Serretti (Univ. Vita-Salute - Sch. of Med., Milan, Italy)
E. Sher (Eli Lilly, Surrey, UK)
S. Shimohama (Kyoto University, Kyoto, Japan)
Y. Shirayama (Chiba Univ.Graduate Sch.Med., Chiba, Japan)
Y. Shoenfeld (Tel-Aviv Univ., Tel-Aviv, Israel)
M. Simonato (University of Ferrara, Ferrara, Italy)
R. Sindelar (The Univ. of British Columbia, Vancouver, Canada)
A.M. Slassi (NPS Pharmaceuticals, Ontario, Canada)
D.H. Small (Monash University, Melbourne, Australia)
M.A. Smith (Case Western Reserve University, Cleveland, Ohio, OH, USA)
K.F.A. Soliman (Florida A&M University, Tallahassee, FL, USA)
B. Solomon (Tel-Aviv University, Tel-Aviv, Israel)
A. Sommer (Univ. of Ulm, Ulm, Germany)
G. Spadoni (University of Urbino, Urbino, Italy)
G. Spalluto (Università di Trieste, Triesta, Italy)
H. Stark (Institut fuer Pharmazeutische Chemie, Frankfurt, Germany)
D.J. Stein (University of Stellenbosch, Cape Town, South Africa)
M.-K. Sun (Blanchette Rockefeller Neurosci. Inst., Rockville, MD, USA)
J.Y. Sze (University of California Irvine, Irvine, CA, USA)
D.-X. Tan (University of Texas, San Antonio, TX, USA)
R.E. Tanzi (Harvard Medical School, Charlestown, MA, USA)
I. Tarnawa (Gedeon Richter Ltd., Budapest, Hungary)
T.Tatlisumak (Helsinki Univ.Central Hospital, Helsinki, Finland)
M. Tricklebank (Lilly Research Centre, Surrey, UK)
P. Taupin (National Univ. of Singapore, Singapore)
H. Ulrich (Universidade de Sao Paulo, Sao Paulo, Brazil)
R. Vandenberg (University of Sydney, Sydney, Australia)
J. Venugopal (Novartis Research Foundation, Basel, Switzerland)
A.N. Vgontzas (Penn State College of Med., Hershey PA , USA)
E. Vieta (University of Barcelona, Barcelona, Spain)
B. Vincent (Institut. Pharmacol. Molec. Cellulaire, CNRS, Valbonne, France)
R. Volpini (Università di Camerino, Camerino, Italy)
M.W. Walter (Eli Lilly and Company Ltd., Surrey, UK)
J.W.F. Wasley (Simpharma LLC, Guilford, CT, USA)
G. Wegener (Univ. of Aarhus, Risskov, Denmark)
D.R. Wesson (CNS Medications Development, Oakland, California, USA)
A. West (University of Tasmania, Hobart, Australia)
A.R. White (The University of Melbourne, Melbourne, Australia)
G.L. Willis (The Bronowski Inst. of Behav. Neurosci., Victoria, Australia)
J.Z. Wu (Valeant Pharmaceuticals International, California, CA, USA)
J.K. Yao (VA Pittsburgh Healthcare System, Pittsburgh, PA, USA)
P. Yogeeswari (Biral Inst.Technology & Science, Rajasthan, India)
M.B.H. Youdim (Technion-Fac.of Med., Haifa, Israel)
F.C. Zhou (Indiana University School of Medicine, Indianapolis, IA, USA)
A. Zine (Universite de Montpellier, Montpellier, France)